N/A
Completed N=32
Evaluating the Feasibility of VR for Pediatric Renal Biopsies
Pain, Procedural · Procedural Anxiety · Sedation Complication
Source: ClinicalTrials.gov NCT05267704 ↗
Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Number of Participants Who "Strongly Agreed" They Would Recommend VR to Others Undergoing Similar Procedures — 0; 32 participants (patients)
Summary
The purpose of this study is to assess the use of virtual reality (VR) as an adjunct or alternative to pharmacologic sedation in pediatric patients undergoing renal biopsy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who "Strongly Agreed" They Would Recommend VR to Others Undergoing Similar Procedures |
0; 32 | — |
| PRIMARY Number of Parents Who "Agreed" or "Strongly Agreed" They Would Recommend VR to Others Undergoing Similar Procedures |
3; 29 | — |
| SECONDARY Mean Difference in Self-reported Procedural Anxiety (Change in Childhood Anxiety Meter) |
3.47 | 0.001 sig |
| SECONDARY Mean Difference in Self-reported Procedural Anxiety (Change in Child Fear Scale) |
1.47 | 0.001 sig |
Eligibility Criteria
Inclusion Criteria
- Patients age 5-17 receiving a renal biopsy at the University of California, San Francisco (UCSF) Benioff Children's Hospital
Exclusion Criteria
- Patients who cannot lie supine for their renal biopsy will be excluded from the study
- Patients with injuries to the head/face that would prohibit wearing a headset
- Patients with loss of consciousness, altered mental status, life-threatening injuries/illness or multi-trauma
- Patients with open skin, lice, scabies, or other infectious skin conditions on the head/face
- Patients with a history of or current symptoms of vertigo
- Patients who are blind
- Patients with significant developmental or cognitive delays who may not be able to engage with or tolerate the virtual reality environment, as determined by their parent/caregiver
- Patients on whom the VR headset does not fit appropriately
Data sourced from ClinicalTrials.gov (NCT05267704). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.